Walter Wu

Walter is a Partner in the Intellectual Property group and serves as head of the firm’s Palo Alto office.

Walter specializes in patent prosecution and portfolio strategy for emerging companies in the life sciences, and patent due diligence for life science investors. His clients and target companies are active in the digital health, medical diagnostics, bioinformatics, ophthalmic, wound care and ENT fields. His transactional experience includes Alcon’s licensing of the Google Smart Lens technology and Auris Surgical Robotics’ acquisition of Hansen Medical. He has developed patent strategies for inter partes reviews and litigation matters involving surgical robots and prosthetic limbs, and is an expert on clinical, marketing and biostatistical issues relating to biotech and pharmaceutical patent litigation, including trial experience in Pfizer Inc. v. Ranbaxy Laboratories Ltd. involving Lipitor.

Walter received his medical degree from the UC Davis School of Medicine, where he was a UC Regents Scholar. During medical school, he completed policy fellowships at the National Governors' Association and the Food and Drug Administration. Walter is a licensed physician and was board-certified in internal medicine from 2000 to 2010. Before attending law school, he was a chief resident and clinical instructor at the UCLA School of Medicine.